Cindy Shupe
Primary Care · Council Bluffs, IANPI 1578071320
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for primary care clinicians in IA, where the typical reported total is $294.
Across 2 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$25
- Smith+Nephew$21
What the payments were for
- Food & beverage$46100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 1 | $25 |
| Smith+Nephew | 1 | $21 |
How this compares
$46 in reported general payments places this provider in the 15th percentile of 36 primary care providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 181 | $52,959 |
| NuedextaDextromethorphan Hbr/Quinidine | 19 | $14,920 |
| JardianceEmpagliflozin | 45 | $13,415 |
| TrulicityDulaglutide | 12 | $12,436 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $9,166 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $8,955 |
| FarxigaDapagliflozin Propanediol | 27 | $7,896 |
| EntrestoSacubitril/Valsartan | 22 | $7,530 |
| TradjentaLinagliptin | 24 | $6,272 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $6,122 |
| Atorvastatin Calcium | 235 | $4,591 |
| Glucagon Emergency KitGlucagon | 17 | $4,548 |
| MyrbetriqMirabegron | 17 | $4,246 |
| LokelmaSodium Zirconium Cyclosilicate | 14 | $3,265 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $2,874 |
Paid to pharmacies, not to this prescriber.
Other primary care in Council Bluffs
- Emily WickhamCouncil Bluffs$7K
- Catherine VailCouncil Bluffs$748
- Roshani KandelCouncil Bluffs$285
- Breanna FinleyCouncil Bluffs$36
- Erin SwailesHiawatha$4K
- Jessica OgdenNewton$2K
- Jody HorstmanWest Des Moines$2K
- Chimene CobbLenox$2K
- Mary PedersenJefferson$1K
- Jamie HicksMilford$847
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.